Cel Sci CVM
NYSE CVM
$1.32 -0.08 (-5.71%)
At close: Nov 11, 2026 · 4:00 PM EST

Cel Sci (CVM) Return on Sales [ROS] (2010 - 2023)

Updated

Cel Sci (CVM) recorded Return on Sales [ROS] of -27366.26% in fiscal Q3 2017 (quarter ended Jun 30, 2017), down 22822.20 percentage points from -4544.06% a year earlier.

Analysis

Cel Sci (CVM) Return on Sales [ROS] (2010 - 2023) Analysis & Trends

On a TTM basis, Cel Sci's Return on Sales [ROS] came in at -9481.25% as of Jun 30, 2017.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Cel Sci 58.11 Mn 32.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -16,185.01%
Mar 31, 2023 -5,140.26%
Sep 30, 2022 -2,360.86%
Mar 31, 2021 -3,272.67%
Mar 31, 2020 -39,718.06%
Jun 30, 2019 -514.63%
Jun 30, 2017 -27,366.26%
Jun 30, 2016 -4,544.06%
Jun 30, 2015 -91,484.84%
Mar 31, 2015 -38,283.66%
Jun 30, 2011 -6,260.41%
Jun 30, 2010 -10,984.01%
API Access

Cel Sci Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CVM&period=max&api_key=YOUR_API_KEY